Head to Head Comparison: Doximity (DOCS) versus Its Peers

Doximity (NYSE:DOCS) is one of 93 publicly-traded companies in the “Healthcare Technology” industry, but how does it weigh in compared to its rivals? We will compare Doximity to related companies based on the strength of its dividends, institutional ownership, profitability, earnings, analyst recommendations, risk and valuation.

Institutional & Insider Ownership

87.2% of Doximity shares are held by institutional investors. Comparatively, 42.4% of shares of all “Healthcare Technology” companies are held by institutional investors. 31.8% of Doximity shares are held by insiders. Comparatively, 16.2% of shares of all “Healthcare Technology” companies are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Analyst Recommendations

This is a summary of recent recommendations and price targets for Doximity and its rivals, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Doximity	3	14	8	0	2.20
Doximity Competitors	451	1531	2741	89	2.51

Doximity presently has a consensus price target of $30.45, suggesting a potential downside of 6.32%. As a group, “Healthcare Technology” companies have a potential upside of 45.51%. Given Doximity’s rivals stronger consensus rating and higher possible upside, analysts clearly believe Doximity has less favorable growth aspects than its rivals.

Volatility & Risk

Doximity has a beta of 1.29, suggesting that its share price is 29% more volatile than the S&P 500. Comparatively, Doximity’s rivals have a beta of 1.13, suggesting that their average share price is 13% more volatile than the S&P 500.

Valuation & Earnings

This table compares Doximity and its rivals gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Doximity	$655.57 million	$196.05 million	45.15
Doximity Competitors	$342.08 million	-$24.15 million	12.97

Doximity has higher revenue and earnings than its rivals. Doximity is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.

Profitability

This table compares Doximity and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Doximity	25.48%	18.06%	15.40%
Doximity Competitors	-778.93%	-33.97%	-15.65%

Summary

Doximity beats its rivals on 9 of the 13 factors compared.

Doximity Company Profile

Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company’s cloud-based platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical companies and health systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.